Simulations of life — in health and disease

Computational models that shed light on how we age, how cancer drugs work (or don’t work), how bacteria evade antibiotics and more highlighted in a recent Exploring Frontiers symposium. See selected recorded talks from the event here.

Read our roundup ►︎

Stories

How do living creatures take shape?

This spring, an Exploring Frontiers symposium delved into the research of dynamic morphogenesis, or “nature’s blueprint.”

Read more ►︎

Advancing leading edge cancer research

A three-way $4.5 million collaboration launched this summer between The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research, and The Paul G. Allen Frontiers Group will drive an innovative new funding initiative for new cancer therapies.

Read the announcement ►︎

Neurons tied to multiple sclerosis’ brain shrinkage

A new study co-led by Allen Distinguished Investigator David Rowitch identifies a type of brain cell that withers away in the late stages of this disease.

Explore more ►︎

Gene drives get a precision upgrade

Method to fine tune DNA could be used to engineer malaria-resistant mosquitoes, reduce pesticide use, boost growth of certain crops.

Read more ►︎

Allen Frontiers Symposium 2019

Join us October 16 and 17 in Boston for the 2019 Allen Frontiers Symposium, a two-day symposium highlighting the research of The Paul G. Allen Frontiers Group awardees.

Learn more and register ►︎

In the News

A Scientist’s Guide to the ‘Exploring Frontiers Symposium: Predicting Biology’ at the Allen Institute

UW Medicine, July 29, 2019

Leukemia & Lymphoma Society Announces $4.5 Million Collaboration

Philanthropy News Digest, July 16, 2019

Our bodies are full of electricity that could help us fight cancer

Quartz, May 30, 2019

Jay Shendure’s cool job using genome science to assess the risk of disease

Seattle Times, May 29, 2019

New role unlocked for nervous system in regeneration

Drug Target Review, May 1, 2019